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Aromatic amines have been studied for more than a
half-century as model carcinogens representing a class
of chemicals that form bulky adducts to the C8 position
of guanine in DNA. Among these guanine adducts, the
N-(2-deoxyguanosin-8-yl)-aminofluorene (G-AF) and
N-2-(2-deoxyguanosin-8-yl)-acetylaminofluorene (G-
AAF) derivatives are the best studied. Although G-AF
and G-AAF differ by only an acetyl group, they exert
different effects on DNA replication by replicative and
high-fidelity DNA polymerases. Translesion synthesis of
G-AF is achieved with high-fidelity polymerases,
whereas replication of G-AAF requires specialized by-
pass polymerases. Here we have presented structures of
G-AF as it undergoes one round of accurate replication
by a high-fidelity DNA polymerase. Nucleotide incorpo-
ration opposite G-AF is achieved in solution and in the
crystal, revealing how the polymerase accommodates
and replicates past G-AF, but not G-AAF. Like an un-
modified guanine, G-AF adopts a conformation that al-
lows it to form Watson-Crick hydrogen bonds with an
opposing cytosine that results in protrusion of the bulky
fluorene moiety into the major groove. Although incor-
poration opposite G-AF is observed, the C:G-AF base
pair induces distortions to the polymerase active site
that slow translesion synthesis.
Metabolic activation of aromatic amines ultimately gener-
ates electrophilic arylnitrenium ions that attack DNA to yield
guanine adducts that impede replication and induce mutations
that underlie tumorigenesis (Fig. 1) (for reviews, see Refs. 1, 2).
These aromatic amine adducts, like other types of DNA dam-
age induced by radiation or exposure to chemical carcinogens,
fall into one of two classes with respect to DNA replication by
replicative polymerases: lesions that block replication and le-
sions that slow replication. The N-2-(2-deoxyguanosin-8-yl)-
acetylaminofluorene (G-AAF)1 adduct belongs to the class of
lesions that blocks replication (3–7) and requires that replica-
tive polymerases be transiently replaced by specialized poly-
merases, most of which belong to the Y family of DNA poly-
merases, to achieve translesion synthesis (8). Bypass of
blocking lesions thus involves the concerted action of replica-
tive and specialized DNA polymerases, a process described by
the so-called “polymerase switch model” (3, 9–11). By contrast,
N-(2-deoxyguanosin-8-yl)-aminofluorene (G-AF) is bypassed
by high-fidelity polymerases (4), although less rapidly than an
unmodified template base (7, 12–14).
The different effects of G-AAF and G-AF on replication have
been postulated to depend upon the conformation these ad-
ducts can adopt (for a review, see Ref. 2). In duplex DNA, G-AF
induces subtle structural alterations to preferentially adopt a
stable “outside binding” anti conformation, where the guanine
retains cognate Watson-Crick bonds with an opposing cytosine
as the fluorene ring projects into the major groove (15–19).
G-AAF is restricted from adopting this anti conformation by its
N-acetyl group. As a consequence, G-AAF adducts impose a
major destabilization of the helix by adopting an “inserted” syn
conformation where the fluorene ring intercalates into the
DNA, displacing the bases to partially denature the helix (17,
20–29). Although the conformations of aminofluorene adducts
in DNA duplexes in the absence of protein have been studied by
NMR and molecular dynamics simulations (16, 19, 30–34),
there is no a priori expectation that these conformations are
adopted in the context of a polymerase active site, because it is
not known what effect the polymerase structure has on the
allowed conformations of G-AF and G-AAF.
Mechanisms of high-fidelity replication that are shared in
large part by all polymerases, have been revealed by structural
studies of DNA polymerase complexes (35–39) in combination
with extensive enzyme kinetic studies (40–45) and are well
represented by our model system, the thermophilic Bacillus
DNA polymerase I fragment (BF) that is capable of catalyzing
DNA replication in a crystal (46, 47). During the replicative
cycle, the high-fidelity polymerase subjects bases and base
pairs to conformational and geometric scrutiny through a se-
ries of sites to achieve accurate replication (Fig. 1B). Prior to
incorporation, a template base is sequestered at the preinser-
tion site, a pocket with steric restrictions imposed by the sur-
rounding O and O1 helices. Upon a conformational change of
these helices from an “open” to a “closed” conformation, the
template base transitions to the insertion site where it must
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adopt a anti conformation to form a Watson-Crick base pair
with the incoming dNTP. At the insertion site, base pairs that
exhibit the shape and geometry of Watson-Crick base pairs are
selected for, whereas base pairs that do not are selected
against. Following formation of the new phosphodiester bond,
the polymerase readopts the open conformation and the newly
formed base pair translocates to the postinsertion site where
polymerase side chains interact with the minor groove of cor-
rectly formed base pairs. The extensive interactions between
the DNAminor groove and the polymerase surface suggest that
DNA adducts at the major groove are better tolerated than
adducts that protrude into the minor groove. Only by adopting
an anti conformation could G-AF and G-AAF project the fluo-
rene moiety into the major groove, thereby retaining protein-
DNA interactions important to further DNA synthesis.
We have determined structures of G-AF as it undergoes one
round of accurate replication. At the preinsertion site, G-AF
adopts a syn conformation compatible with dNTP incorpora-
tion, well positioned to maneuver a transition to an anti con-
formation at the insertion site where it can pair with an in-
coming dCTP. By contrast, G-AAF cannot maneuver this
transition as it is restricted from adopting an anti conformation
because of steric hindrance imposed by its N-acetyl group.
Consistent with both structural and biochemical data, incorpo-
ration of dCTP opposite G-AF, but not G-AAF, was observed.
Following incorporation of dCTP in the crystal, G-AF adopts an
anti conformation at the postinsertion site, forming Watson-
Crick hydrogen bonds with the opposing cytosine as the fluo-
rene moiety projects into the solvent-exposed major groove.
Structures of G-AF prior to and following dCTP incorporation
reveal distortions to the polymerase active site that resemble
distortions induced by DNA mismatches and lesions that re-
duce the efficiency of DNA replication.
EXPERIMENTAL PROCEDURES
Preparation of AF-modified DNA Duplexes—Chemical modification
of an oligonucleotide (5-ACTGCACCATCCCTp) containing a single
guanine residue with N-acetoxy-N-2-acetylaminofluorene to yield an
oligonucleotide containing a single G-AAF adduct was performed as
previously described (48). The G-AAF-containing nucleotide was con-
verted to G-AF by alkaline deacetylation in the presence of 2-mercap-
toethanol to prevent further oxidation (4, 49, 50). Both G-AAF- and
G-AF-containing oligonucleotides were purified by reverse phase high
performance liquid chromatography (48), lyophilized, and then dis-
solved in a solution containing 10 mM cacodylate buffer (pH 7.5), 10 mM
MgSO4, 50 mM NaCl, 0.5 mM EDTA, and 2 mM 2-mercaptoethanol.
AF-modified oligonucleotide was annealed to complementary oligonu-
cleotide, 11-mer (5-AGGGATGGTGC) or 10-mer (5-AGGGATGGTG),
to generate a DNA duplex where the AF lesion was positioned at the
template n-1 and n position, respectively.
In Vitro Nucleotide Incorporation Opposite AF and AAF by BF—AF-
or AAF-modified template oligonucleotides and an unmodified template
identical in sequence were annealed to a 5 32P-labeled complementary
10-mer oligonucleotide positioning G-AF, G-AAF, or an unmodified
guanine as the n template base. The primer was extended (standard
reaction conditions 50 mM Tris-HCl, pH 8.0, 5 mM MgCl2 1 mM dithio-
threitol, 50 g ml1 bovine serum albumin, and 4% glycerol, 200 nM
annealed duplex, 0.1 mM dNTP, 20 °C) with 0.5 and 1.0 nM BF for
nucleotide incorporation opposite unmodified guanine and G-AF or
G-AAF, respectively. At each time point, 10 l of the reaction mix was
withdrawn and quenched with 30 mM EDTA (final concentration).
Primers and products were separated by electrophoresis (15% poly-
acrylamide/8 M urea) and visualized (Amersham Biosciences 445SI
Phosphorimager).
Crystallization of BF with AF-modified DNA Duplexes and Catalysis
in the Crystal—Purification of BF and crystallization with DNA sub-
strates were performed as described previously (46, 47) with AF-mod-
ified DNA duplexes used in place of unmodified DNA duplexes. Incor-
poration of dCTP opposite G-AF was performed by transferring BF-
DNA co-crystals into solutions containing 30 mM dCTP as described
previously for accurate DNA synthesis in the BF-DNA crystal (47).
Data Collection, Structure Determination, and Superposition—Crys-
tals were transferred to cryoprotectant solution (60% saturated ammo-
nium sulfate, 24% sucrose, 100 mM MES, pH 5.8) prior to being flash-
frozen in liquid nitrogen. Data were collected at 98 K using a RAXIS-II
or RAXIS-IV detector (Molecular Structure) on a Rigaku rotating anode
x-ray generator operated at 50 mA and 100 kV with  (CuK)  1.542
Å and processed using DENZO and SCALEPACK (51). Diffraction
resolution was limited by the edge of the detector. Data for the BF
co-crystal structure with C:G-AF at the post-IS was 77% complete at 2.0
Å. The co-crystals belong to spacegroup P212121 and contain one mole-
cule/asymmetric unit. Phases were calculated using molecular replace-
ment (PDB accession code 2BDP as the probe) and models refined using
crystallography NMR software (52). Force field and topology parame-
ters allowing multiple sugar pucker conformations were used for the
DNA and were modified to include parameters for the G-AF residue
generated using XPLO2D (53). The structures were visualized and
modified with the program O (54). Quality of the final models was
assessed using PROCHECK (55) and REDUCE (56). Superpositions of
the C atoms of BF residues 646–655, 823–838, and 863–869 were
done using LSQMAN (57).
FIG. 1. A, chemical structures of G-AF and G-AAF. dR, deoxyribose
ring. The proton and the N-acetyl group that differentiate G-AF from
G-AAF are shown in orange. B, schematic of the polymerase active site.
Sites through which the template base (red) traverses during replica-
tion are shown (see the Introduction for description).
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RESULTS
Replication of G-AF and G-AAF in Solution and in BF Crys-
tals—AF- and AAF-modified DNA duplexes were used to de-
termine the ability of BF to incorporate nucleotide opposite
G-AF and G-AAF in solution and in the crystal. Incorporation
of dCTP opposite G-AF is observed in solution but occurs less
efficiently than dCTP incorporation opposite unmodified gua-
nine (Fig. 2A). Replication fidelity is retained as extended
primers were only observed with dCTP and not other dNTPs.
By contrast, G-AAF blocks DNA replication by BF as incorpo-
ration of dCTP was not observed (Fig. 2B).
The ability to observe DNA synthesis in BF polymerase
crystals allowed us to determine structures of G-AF before (Fig.
3) and after (Fig. 4) dCTP incorporation. These structures,
solved to 2.1 and 2.0 Å resolution, respectively (Table I), show
G-AF positioned at two sites: the template preinsertion site (n)
and the postinsertion site (n-1). The latter structure was indis-
tinguishable from a co-crystal structure of BF bound to a DNA
duplex that contained a C:G-AF (primer:template) base pair at
the postinsertion site (Table I).
G-AF at the Template Preinsertion Site—Positioning of the
G-AF template base in the preinsertion site results in localized
structural perturbations (Fig. 3). The G-AF template base (n)
adopts a syn conformation and is accommodated by the prein-
sertion site, but with a disordered O1 helix. The fluorene moi-
ety makes extensive van der Waals contacts with the preinser-
tion site surface and is essentially buried from solvent
exposure, whereas the base of the G-AF residue forms a stack-
ing interaction with the sugar of the n1 template base (Fig.
3B). Despite this interaction and the disorder of the O1 helix,
the O helix remains ordered and in an open conformation well
positioned for transfer of the n template base from the template
preinsertion site to the insertion site.
The remainder of the polymerase active site is unperturbed
by the presence of G-AF at the template preinsertion site (Fig.
3A). Hydrogen bonds between protein residues that read the
DNAminor groove (Gln-797 and Arg-615) and the n-1 base pair
are retained. Both the primer and template bases adopt con-
formations identical to those of cognate bases at this site.
Consequently, there is no distortion of the DNA duplex region,
and positioning of the 3-hydroxyl and assembly of the catalytic
site remain intact.
G-AF at the Postinsertion Site—A nucleotide was incorpo-
rated opposite G-AF in the BF crystal resulting in the forma-
tion of a C:G-AF base pair positioned at the postinsertion site
(Fig. 4). The C:G-AF base pair results in significant distortions
to all active site regions (postinsertion site, insertion site, tem-
plate preinsertion site, DNA duplex region) except for the cat-
alytic site (Fig. 4). These distortions are reminiscent of distor-
tions induced when a G:T mismatch occupies the polymerase
active site (58).
By adopting an anti conformation, G-AF forms Watson-Crick
hydrogen bonds with the opposing cytosine as the AF moiety
projects into the major groove. This conformation resembles the
“external” conformation described in structures of AF in duplex
FIG. 3. Structure of BF with G-AF at the template preinsertion
site. A, structure of BF bound to G-AF at the preinsertion site (blue)
superimposed with a structure of BF with an unmodified base at the
preinsertion site (gray). G-AF is highlighted in red. B, stereoview of
preinsertion site. G-AF is surrounded by electron density contoured at
3.5  and calculated using Fourier coefficients (Fobs  Fcalc)calc with
G-AF omitted from the final model.
FIG. 2. Nucleotide incorporation opposite G-AF and G-AAF in solution. A, single nucleotide extension of primers (10 nucleotides)
annealed to templates containing unmodified guanine or G-AF was attempted using each dNTP (0.1 mM). Concentration of BF used for
incorporation opposite unmodified guanine and G-AF were 0.5 and 1.0 nM, respectively. Approximately 55 and 15% of primers were extended (in
60 s) using unmodified and AF-modified templates, respectively. B, assay for dCTP incorporation opposite G-AAF performed in a manner similar
to that for incorporation opposite G-AF.
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DNA determined by NMR (16). By protruding into the major
groove, the AF moiety blocks the next template base, which is
observed in a stacking interaction with the fluorene moiety,
from occupying the template preinsertion site. A second block
to the preinsertion site is presented by the loop between the O
and O1 helices. The conformation of this loop is altered because
of O and O1 helical distortion that causes Tyr-714 to shift by
2.8 Å from its cognate position.
Disruption of interactions between the template and poly-
merase are also observed at the postinsertion site. Here, the
interaction between Gln-797 and the template minor groove is
lost. The G-AF is rotated away from the polymerase surface
and is displaced by 1.6 Å from its cognate position.
Although G-AF induces distortions to the template and its
interactions with the polymerase active site, distortions to the
primer strand and catalytic site are not observed. The newly
incorporated primer base retains the minor groove interaction
with Arg-615 and the 3-OH is not displaced. Coordination of
the 3-OH by Asp-830 remains intact for the next 3- to 5-
nucleotidyl transfer reaction.
Structure Determination of BF Polymerase Complexes con-
taining G-AAF-modified DNA Templates—To obtain structures
of the G-AAF adduct placed at the preinsertion and postinser-
tion sites, experiments analogous to those done to capture
G-AF at these sites were performed. The structure of a DNA
duplex designed to position G-AAF at the preinsertion site
was determined to 2.1 Å resolution. In this complex the
protein adopts an open conformation and the DNA duplex
region, catalytic site, and postinsertion site appear unper-
turbed. The preinsertion site, although well ordered, is
empty. Instead of binding in the preinsertion site, the G-AAF
n template base is positioned over the site and is partially
disordered. Attempts to incorporate dCTP opposite G-AAF in
the BF crystal resulted in structures that are indistinguish-
able from the initial complex, suggesting that incorporation
did not take place.
TABLE I
Data collection and refinement statistics
R.m.s., root mean square. Pre-IS, pre-insertion site. Post-IS, post-insertion site. Rsym  ((I  I))/(I), where I is the average intensity of
multiple measurements. Rcryst and Rfree (Fobs Fcalc)/(Fobs). Rfree was calculated over 5% of the amplitudes not used in refinement. *, Values
in parentheses correspond to those in the outer resolution shell.
Crystal G-AF G-AAF C:G-AF C:G-AF (co-crystal)
Position of lesion Pre-IS Pre-IS Post-IS Post-IS
Resolution range, Å 50–2.1 50–2.1 35–2.0 20–1.8
Outer shell 2.14–2.1 2.14–2.1 2.03–2.0 1.83–1.8
Rsym, %* 8.9 (17.4) 5.5 (14.5) 8.4 (30.4) 5.1 (17.3)
Unique reflections 51,039 51,224 59,431 81,676
Total reflections 1,036,814 722,258 848,657 632,374
Mean I/I* 11.5 (3.6) 16.8 (3.9) 14.9 (2.4) 21.8 (3.4)
Completeness, %* 84.3 (51.9) 92.0 (73.9) 97.9 (85.1) 82.5 (52.1)
Rcryst, % 21.0 22.7 21.6 20.5
Rfree, % 24.2 26.8 24.9 23.6
R.m.s. deviation bond length, Å 0.006 0.006 0.006 0.005
R.m.s. deviation bond angle, ° 1.2 1.2 1.2 1.2
Average B-value, Å2 40.4 25.2 31.9 22.5
 A coordinate error, Å2 0.18 0.14 0.16 0.17
FIG. 4. Structure of BF with G-AF at the postinsertion site. A, structure of BF bound to G-AF at the postinsertion site (blue) superimposed
with a structure of BF bound to an unmodified base at the postinsertion site (gray). G-AF (red) adopts an anti conformation and obstructs the n1
template base from occupying the preinsertion site that is itself disordered. B, C:G-AF base pair surrounded by electron density contoured at 3.5
 and calculated using Fourier coefficients (Fobs  Fcalc)calc with C:G-AF omitted from the final model. Hydrogen bonds (dashed lines) are shown
accompanied with bond lengths.
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DISCUSSION
Anti Conformation of G-AF Promotes Accurate Replication—
Structures of G-AF as it undergoes one round of replication
reveal that G-AF transitions from a syn conformation at the
preinsertion site to an anti conformation at the postinsertion
site. In so doing, two important features are observed: 1) ability
to form cognate Watson-Crick hydrogen bonds with an opposing
cytosine, and 2) protrusion of the AF moiety into the solvent-
exposed major groove. These features promote accurate incorpo-
ration of dCTP over mutagenic incorporation of other dNTPs
opposite G-AF and account for the low frequency of mutations
(103 G3T transversions) observed in vivo (59, 60).
Unlike G-AF, G-AAF is sterically restricted to a syn confor-
mation by the N-2-acetyl group. Its transition to anti is se-
verely impaired but not completely prohibited. The conforma-
tion of AAF in a DNA duplex determined in the absence of
protein by biophysical techniques and NMR reveals a highly
disruptive inserted conformation in which the fluorene ring
stacks with helix base pairs, thereby displacing the attached
guanine and sugar into the minor groove (insertion-denatur-
ation model) (17, 20, 22, 28). It is unlikely that an inserted
conformation of G-AAF would be accommodated by the BF
active site in a manner amenable to replication. Correspond-
ingly, the inability to incorporate any dCTP opposite G-AAF in
solution and in the crystal reflects the blocking effect of G-AAF
on replication by BF and other high-fidelity DNA polymerases.
By contrast, bypass polymerases such as Pol V from Esche-
richia coli appear to be able to efficiently copy G-AAF-contain-
ing DNA templates (8). Bypass of G-AAF adducts by several
specialized eukaryotic DNA polymerases has also been docu-
mented (see review Ref. 61).
Lesion Bypass of G-AF by BF—Despite the bulkiness of
G-AF, nucleotide incorporation opposite the lesion is observed
in solution and in the crystal. Primer extension assays demon-
strate that nucleotide incorporation opposite G-AF proceeds,
albeit less efficiently than replication of undamaged DNA, and
dCTP is strongly preferred over all other dNTPs (Fig. 2A).
Structures of G-AF at the pre- and postinsertion sites illustrate
how nucleotide incorporation occurs despite distortions in-
duced by G-AF to the template strand and polymerase.
Before incorporation of dCTP, G-AF occupies the preinser-
tion site in a manner similar to an unmodified template base.
Although there are localized distortions of the protein in the
vicinity of G-AF, the presence of G-AF at the preinsertion site
does not affect the catalytic site, the postinsertion site, or the O
helix. The presence of an active site that remains largely un-
perturbed permits nucleotide incorporation opposite G-AF. In
pairing with cytosine, G-AF adopts an anti conformation to
form cognate Watson-Crick hydrogen bonds as the AF moiety
protrudes into the major groove. The AF moiety is accommo-
dated by the polymerase because the major groove is predom-
inantly solvent-exposed, whereas the minor groove interacts
extensively with the polymerase. The ability of G-AF to adopt
conformations at the preinsertion and insertion sites that do
not disrupt assembly of the catalytic site promotes nucleotide
incorporation opposite G-AF.
Following dCTP incorporation opposite G-AF, the newly
formed C:G-AF base pair induces distortions to the polymerase
active site that affect subsequent DNA synthesis. The most
significant of these distortions are to the preinsertion site that
is blocked to the next template base by two structural features:
the projection of the fluorene moiety over the preinsertion site
and the distorted conformation of the O and O1 helices. Dis-
ruption of the preinsertion site is accompanied by disruptions
to the minor groove interactions between the template and the
polymerase. These interactions are disrupted as a consequence
of template distortions that displace the n-1 template base.
Similar distortions to the template and preinsertion site are
observed when certain DNA mismatches or the non-bulky ox-
idative DNA lesion 8oxoguanine are bound at the polymerase
active site (58, 62). These distortions likely account for ob-
served reductions in rates of DNA synthesis past mismatches,
8oxoguanine, and G-AF by BF (62) and other related high-
fidelity polymerases (12, 45, 63–67).
Biological Significance of Stalled or Blocked Replication—
Structures of G-AF determined during the course of one repli-
cation cycle show us that mechanisms of high-fidelity replica-
tion can accommodate non-cognate template bases and
accurately synthesize DNA despite distortions that cause the
polymerase to stall. Accommodation of lesion-induced template
distortions by high-fidelity polymerases has also been observed
for other types of DNA lesions that are less bulky than G-AF or
G-AAF but also impede DNA replication. Structures of 8ox-
oguanine, cyclobutane pyrimidine dimers, or abasic lesions
bound by T7 DNA polymerase (67, 68), RB69 polymerase (69,
70), or BF (62) reveal that template distortions induced by
these lesions do not necessarily result in distortions to the
polymerase active site. However, interactions between the le-
sioned duplex and the polymerase are lost, thereby impairing
lesion bypass and promoting partitioning of the DNA duplex to
the exonuclease domain in the case of RB69 (69, 70). Rather
than bypass lesions using mechanisms of replication for un-
modified DNA, high-fidelity polymerases employ non-tem-
plated incorporation of dATP (the “A” rule; Ref. 71) to replicate
cyclobutane pyrimidine dimers (68) and abasic lesions (70) and
alternate modes of base pairing to replicate 8oxoguanine (62,
67). Although these mechanisms of translesion replication may
not be as efficient as replication of undamaged DNA, they
demonstrate the ability of high-fidelity polymerases to synthe-
size DNA despite lesion-induced distortions to the template or
polymerase active site.
Although bypass of G-AF and other types of DNA lesions is
achieved by high-fidelity polymerases, G-AAF blocks DNA rep-
lication by these polymerases, induces the SOS response, and
requires specialized DNA polymerases for in vivo bypass (72–
76). For replication to occur past G-AAF and other blocking
lesions, the replicative polymerase is replaced by a specialized
lesion bypass polymerase, most commonly a Y family polymer-
ase (the polymerase switch model) (11). Structures of Y family
polymerases bound to DNA lesions reveal features that allow
replication of lesion-modified DNA bases (77–79). Unlike BF, Y
family polymerases do not possess the necessary architecture
to form a preinsertion site. Instead, these enzymes have mod-
ified O and O1 helices or lack them altogether. Consequently,
the DNA template assumes a more linear conformation as it
enters the active site rather than adopting the sharp turn
observed in the context of BF. Replication of bulky adducts is
further facilitated by the relative openness of the Y family
polymerase active site, which can accommodate mismatched
DNA base pairs and DNA lesions (80). Such a site is less likely
to restrict the conformation of large adducts. The syn confor-
mation, to which G-AAF adducts are restricted, may be accom-
modated by the active site of the Y family polymerase  (81),
which is unique among DNA polymerases in that it preferen-
tially drives the templating base to the syn conformation dur-
ing replication (82). The structural features that differentiate
polymerase  and other Y polymerases from high-fidelity poly-
merases indicate how Y polymerases are suited for translesion
replication of conformationally restricted bulky adducts in a
way high-fidelity polymerases are not.
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